Phase II, Placebo Controlled, Parallel Group, Double Blind, Randomised, Multicentre Trial Comparing the Anastrozole (Arimidex)-Placebo Combination to the Anastrozole –ZD1839 (Iressa) Combination as Neoadjuvant Treatment in Postmenopausal Women with Stage I-IIIB (tumour =2cm) Non Inflammatory Breast Cancer and Oestrogen Receptor (ER) and /or Progesterone Receptor (PgR) Positive Tumours)

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].